MAP3K3 and cerebral cavernous malformation: However, the majority of patients typically have a solitary sporadic lesion, with either somatically-acquired loss-of-function variants in a CCM gene or a somatically-acquired, activating variant in MAP3K3, which is negatively regulated by the CSC17.